"A testament to our commitment": 1.9 million doses of NexGard® PLUS donated to animal shelters

A close-up view of a dog's brown eye.

In a significant move towards improving animal welfare, the Boehringer Ingelheim Cares Foundation has donated 1.9 million doses of NexGard® PLUS to animal shelters across the country. The donation, made through the Foundation's Product Donation Program, is valued at $42.6 million.

NexGard® PLUS is a beef-flavored soft chew designed to protect dogs from fleas and ticks, prevent heartworm disease, and treat and control roundworms and hookworms. Since its launch in 2023, over 6 million doses of NexGard® PLUS have been sold.

The Foundation's donation is expected to have a significant impact on the lives of shelter dogs. Parasiticides like NexGard® PLUS play a crucial role in the adoption process, enhancing the health of the dogs and making them more appealing to potential adopters.

The Foundation has partnered with Greater Good Charities to distribute the products to animal shelters in need. Greater Good Charities is an organization dedicated to improving the health and well-being of people, pets and the planet.

Randolph Legg, President and Head of Commercial Business, Boehringer Ingelheim Animal Health USA and board member of the Boehringer Ingelheim Cares Foundation, spoke about the donation. “Boehringer Ingelheim is deeply committed to safeguarding the health and wellbeing of animals in shelters,” said Legg. “Our mission is to ensure they receive the best care possible while they patiently wait for their forever homes. This donation is a testament to our commitment and we hope it will make a significant difference in the lives of animals in need.”

This substantial donation by the Boehringer Ingelheim Cares Foundation is a significant step towards improving the lives of shelter dogs across the country. By providing essential protection against harmful parasites, the Foundation is not only enhancing the health of these dogs but also increasing their chances of finding a loving home.